UnknownPhase 3

Intravitreal Bevacizumab for Management of Active Progressive Proliferative Diabetic Retinopathy (PDR)

IranStarted 2006-03

Plain-language summary

To evaluate the effect of intravitreal bevacizumab on the course of diabetic retinopathy in cases with the signs of active progressive PDR

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Cases of active progressive PDR with history of scatter laser photocoagulation Exclusion Criteria: * history of vitrectomy

Regression of diabetic retinopathy

visual acuity

NCT IDNCT00370721

SponsorShahid Beheshti University of Medical Sciences

Sponsor typeOTHER

Study typeINTERVENTIONAL

Hamid Ahmadieh, MD